Cybin (HELP) Total Non-Current Liabilities (2021 - 2024)

Cybin (HELP) reported Total Non-Current Liabilities of -$10.2 million for Q4 2024, down 33253.61% on a YoY basis from N/an in Q1 2024, and up 31.0% quarter-over-quarter from -$14.8 million in Q3 2024.

Cybin (HELP) Total Non-Current Liabilities (2021 - 2024) Analysis & Trends

Cybin has reported Total Non-Current Liabilities for 4 years, with the latest figure at -$10.2 million in Q4 2024.

  • For the quarter ending Q4 2024, Total Non-Current Liabilities fell 33253.61% year-over-year to -$10.2 million; the trailing twelve-month figure through Dec 2024 stood at -$10.2 million (down 33253.61% YoY), and the FY2024 full-year result was -$11.5 million, changed N/A from the prior year.
  • Total Non-Current Liabilities for Q4 2024 stood at -$10.2 million, up from -$14.8 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $864368.4 in Q1 2021, with the low at -$15.2 million in Q2 2024.
  • Historically, Total Non-Current Liabilities has averaged -$5.2 million across 4 years, with a median of -$4.4 million in 2021.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities jumped 100.64% — and 2024, when it tumbled 33253.61%.
  • Cybin's Total Non-Current Liabilities stood at -$4.4 million in 2021, then dropped by 9.02% to -$4.8 million in 2022, then jumped by 100.64% to $30850.5 in 2023, then plunged by 33253.61% to -$10.2 million in 2024.
  • The last three Total Non-Current Liabilities figures came in at -$10.2 million (Q4 2024), -$14.8 million (Q3 2024), and -$15.2 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Cybin 75.42 Mn 75.42 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -10.23 Mn
Sep 30, 2024 -14.82 Mn
Jun 30, 2024 -15.23 Mn
Mar 31, 2024 -11.53 Mn
Dec 31, 2023 30,850.49
Sep 30, 2023 -3.78 Mn
Jun 30, 2023 173,457.42
Feb 28, 2023 226,867.54
Dec 31, 2022 -4.79 Mn
Sep 30, 2022 -4.90 Mn
Dec 31, 2021 -4.40 Mn
Sep 30, 2021 -4.47 Mn
Jun 30, 2021 626,415.91
Mar 31, 2021 864,368.44